Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Enzyme Replacement Therapy (PERT) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

NCT02985801 is registered in ClinicalTrials.gov with Massimo Raimondo, M.D. as lead sponsor.

NCT NCT02985801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Enzyme Replacement Therapy (PERT) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Lead sponsor
Massimo Raimondo, M.D.
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2016
Completion date
April 30, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, pancreatic enzyme abnormality, pancreatic insufficiency